You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 22, 2024

VANDAZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Vandazole, and what generic alternatives are available?

Vandazole is a drug marketed by Teva Pharms and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in VANDAZOLE is metronidazole. There are eighteen drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vandazole

A generic version of VANDAZOLE was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VANDAZOLE?
  • What are the global sales for VANDAZOLE?
  • What is Average Wholesale Price for VANDAZOLE?
Drug patent expirations by year for VANDAZOLE
Drug Prices for VANDAZOLE

See drug prices for VANDAZOLE

Drug Sales Revenue Trends for VANDAZOLE

See drug sales revenues for VANDAZOLE

Recent Clinical Trials for VANDAZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
New York Medical CollegePhase 4

See all VANDAZOLE clinical trials

Pharmacology for VANDAZOLE

US Patents and Regulatory Information for VANDAZOLE

VANDAZOLE is protected by one US patents.

Patents protecting VANDAZOLE

Vaginal pharmaceutical compositions and methods for preparing them
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms VANDAZOLE metronidazole GEL;VAGINAL 021806-001 May 20, 2005 BX RX No Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Premature patent expiration for: VANDAZOLE

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
⤷  Sign Up VANDAZOLE ⤷  Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.